Published on: July 7, 2013

Dr Dinesh Sharma, writing in Lancet Oncology reports on India’s ban on Dextropropoxyphene. Please see…

India urged to reverse dextropropoxyphene ban

Dinesh C Sharma; Lancet Oncology, Early Online Publication, 5 July 2013

Palliative care experts have urged the Indian Ministry of Health to reverse its decision to ban the manufacture and sale of dextropropoxyphene and formulations that contain it. The ban on the cheapest opioid available for oral use could increase the pain burden of patients with cancer who cannot afford costly alternatives….

Comments are closed.